Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-29 Sale | 2021-12-01 7:07 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 441,290 | $3.9297 | $1,734,150 | 9,607,934 (Indirect) | View |
| 2021-11-17 Sale | 2021-11-19 4:38 pm | Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Chief Executive Officer 10% Owner | 2,747,131 | $2.086 | $5,730,557 | 12,767,435 (Indirect) | View |
| 2021-05-27 Purchase | 2021-06-01 6:42 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 245,020 | $4.4719 | $1,095,693 | 10,049,224 (Indirect) | View |
| 2021-05-24 Purchase | 2021-05-26 4:56 pm | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 398,714 | $3.9571 | $1,577,731 | 9,804,204 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-22 Equity Swap | 2022-08-24 8:19 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 3,519 | $0 | 0 (Indirect) | View |
| 2022-08-22 Disposition | 2022-08-24 8:19 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 3,036 | $0 | 0 (Direct) | View |
| 2022-08-22 Disposition | 2022-08-24 8:17 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 10,186 | $6.23 | 0 (Direct) | View |
| 2022-08-22 Disposition | 2022-08-24 8:17 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 237,893 | $0 | 0 (Direct) | View |
| 2022-08-22 Equity Swap | 2022-08-24 8:17 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 9,607,934 | $6.23 | 0 (Indirect) | View |
| 2022-08-22 Equity Swap | 2022-08-24 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 3,519 | $0 | 0 (Indirect) | View |
| 2022-08-22 Equity Swap | 2022-08-24 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Director 10% Owner | 9,607,934 | $6.23 | 0 (Indirect) | View |
| 2022-06-30 Option Award | 2022-07-05 5:51 pm | N/A 2032-06-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 236 | $0 | 9,618,356 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 5:51 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 236 | $2.7115 | 9,618,356 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:05 pm | N/A 2032-06-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 236 | $0 | 9,618,120 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 236 | $2.72 | 9,618,120 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 5:05 pm | N/A 2032-05-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 189 | $0 | 9,617,837 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 189 | $3.4085 | 9,617,837 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-17 5:07 pm | N/A 2032-05-13 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 188 | $0 | 9,617,647 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-17 5:07 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 188 | $3.4085 | 9,617,647 (Direct) | View |
| 2022-04-29 Option Award | 2022-05-03 5:00 pm | N/A 2032-04-29 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 185 | $0 | 9,617,456 (Direct) | View |
| 2022-04-29 Option Award | 2022-05-03 5:00 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 185 | $3.468 | 9,617,456 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-18 6:31 pm | N/A 2032-04-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 173 | $0 | 9,617,259 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-18 6:31 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 173 | $3.7145 | 9,617,259 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 5:38 pm | N/A 2032-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 177 | $0 | 9,617,090 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 5:38 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 177 | $3.6295 | 9,617,090 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 9:04 pm | N/A 2032-03-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 190 | $0 | 9,616,926 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 9:04 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 190 | $3.366 | 9,616,926 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 5:07 pm | N/A 2032-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 185 | $0 | 9,616,731 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 5:07 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 185 | $3.4765 | 9,616,731 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:05 pm | N/A 2032-02-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 169 | $0 | 9,616,530 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 169 | $3.791 | 9,616,530 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 7:19 pm | N/A 2032-01-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 1,675 | $0 | 9,617,867 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 7:19 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 1,675 | $3.9355 | 9,617,867 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 8:26 pm | N/A 2032-01-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 148 | $0 | 9,614,665 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 8:26 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 148 | $4.182 | 9,614,665 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-14 6:27 pm | N/A 2032-01-12 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 78,552 | $0 | 78,552 (Direct) | View |
| 2021-12-30 Option Award | 2022-01-04 5:05 pm | N/A 2031-12-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 157 | $0 | 9,614,526 (Direct) | View |
| 2021-12-30 Option Award | 2022-01-04 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 157 | $3.9185 | 9,614,526 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 5:58 pm | N/A 2031-12-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 173 | $0 | 9,614,385 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 5:58 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 173 | $3.5785 | 9,614,385 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 5:05 pm | N/A 2031-11-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 186 | $0 | 10,055,515 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 186 | $3.315 | 10,055,515 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 5:05 pm | N/A 2031-11-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 181 | $0 | 10,055,324 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 181 | $3.4085 | 10,055,324 (Direct) | View |
| 2021-10-29 Option Award | 2021-11-02 5:05 pm | N/A 2031-10-29 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 181 | $0 | 10,055,143 (Direct) | View |
| 2021-10-29 Option Award | 2021-11-02 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 181 | $3.417 | 10,055,143 (Direct) | View |
| 2021-10-15 Option Award | 2021-10-19 5:05 pm | N/A 2031-10-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 183 | $0 | 10,054,964 (Direct) | View |
| 2021-10-15 Option Award | 2021-10-19 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 183 | $3.366 | 10,054,964 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 5:05 pm | N/A 2031-09-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 182 | $0 | 10,054,780 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 182 | $3.3915 | 10,054,780 (Direct) | View |
| 2021-09-15 Option Award | 2021-09-17 5:05 pm | N/A 2031-09-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 546 | $0 | 10,054,962 (Direct) | View |
| 2021-09-15 Option Award | 2021-09-17 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 546 | $3.3915 | 10,054,962 (Direct) | View |
| 2021-07-30 Option Award | 2021-08-03 5:05 pm | N/A 2031-07-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 201 | $0 | 10,054,071 (Direct) | View |
| 2021-07-30 Option Award | 2021-08-03 5:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 201 | $3.0685 | 10,054,071 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-19 6:57 pm | N/A 2031-07-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 193 | $0 | 10,053,862 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-19 6:57 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 193 | $3.196 | 10,053,862 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 8:35 pm | N/A 2031-06-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 170 | $0 | 10,053,646 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 8:35 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 170 | $3.638 | 10,053,646 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 5:34 pm | N/A 2031-06-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 148 | $0 | 10,053,454 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 5:34 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 148 | $4.165 | 10,053,454 (Direct) | View |
| 2021-05-28 Option Award | 2021-06-02 5:03 pm | N/A 2031-05-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 169 | $0 | 10,053,327 (Direct) | View |
| 2021-05-28 Option Award | 2021-06-02 5:03 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 169 | $3.655 | 10,053,327 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 8:26 pm | N/A 2031-05-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 193 | $0 | 9,409,448 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 8:26 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 193 | $3.196 | 9,409,448 (Direct) | View |
| 2021-04-30 Option Award | 2021-05-04 8:05 pm | N/A 2031-04-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 163 | $0 | 9,409,225 (Direct) | View |
| 2021-04-30 Option Award | 2021-05-04 8:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 163 | $3.774 | 9,409,225 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 9:38 pm | N/A 2031-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 173 | $0 | 9,409,498 (Direct) | View |
| 2021-04-15 Option Award | 2021-04-19 9:38 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 173 | $3.553 | 9,409,498 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-02 7:35 pm | N/A 2031-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 172 | $0 | 9,409,324 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-02 7:35 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 172 | $3.604 | 9,409,324 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 4:43 pm | N/A 2031-03-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 127 | $0 | 9,409,107 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 4:43 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 127 | $4.8535 | 9,409,107 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 4:04 pm | N/A 2031-03-15 | Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer | 37 | $0 | 15,517,223 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 4:04 pm | N/A N/A | Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer | 37 | $16.22 | 15,517,223 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:36 pm | N/A 2031-02-26 | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 139 | $0 | 9,408,992 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:36 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Hearne Michael S Chief Financial Officer | 139 | $4.454 | 9,408,992 (Direct) | View |